Smoking Cessation Pilot Program on 9 South
试验速览
- 阶段
- 早期 1 期
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Change in Self-reported attempts to quit smoking
研究概览
简要总结
The investigators are implementing a stepwise approach to cessation with a public health focus to improve health outcomes for the investigators' pediatric patients. The investigators are focusing on addressing caregiver smoking as a modifiable risk factor during time of child's hospitalization as a window of opportunity to provide counseling and education to families on secondhand and third hand smoke exposure as well as information on NRT products to heighten caregiver contemplation for quitting. One of the central goals of the investigators' project is to increase immediate access to Nicotine Replacement Therapy (NRT) resources for families during hospitalization which pediatric providers could potentially dose and prescribe to caregivers who are screened positive for smoking. Long-term cessation care is provided by referrals to both the MD Quitline and the John Hopkins Tobacco Treatment Clinic. Both are provided to allow participants options that the participants would find preferable from an insurance and provider perspective.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Caregivers of patients on an inpatient unit at Johns Hopkins Children's Center who self-identify as tobacco users and wish to initiate tobacco cessation
排除标准
- •Pregnant or breast feeding maternal caregivers.
研究组 & 干预措施
Cessation intervention
All participants will receive nicotine replacement therapy and a referral to both Maryland Quitline and Johns Hopkins Tobacco Treatment Clinic for continued cessation care.
Nicotine replacement therapy: Nicoderm patches, gum, lozenges
- Low nicotine dependence: Lozenge (2 mg) or Gum (2 mg) or Patch (7 mg)
- Moderate nicotine dependence: Patch (14 mg) and Lozenge (2 mg) or Gum (2 mg)
- High nicotine dependence: Patch (21 mg) and Lozenge (4 mg) or Gum (4 mg)
Regardless of the level of nicotine addiction and subsequent dose of nicotine replacement therapy (NRT), participants of this trials are described as "recipients of NRT products".
干预措施: Nicotine lozenge (Drug)
Cessation intervention
All participants will receive nicotine replacement therapy and a referral to both Maryland Quitline and Johns Hopkins Tobacco Treatment Clinic for continued cessation care.
Nicotine replacement therapy: Nicoderm patches, gum, lozenges
- Low nicotine dependence: Lozenge (2 mg) or Gum (2 mg) or Patch (7 mg)
- Moderate nicotine dependence: Patch (14 mg) and Lozenge (2 mg) or Gum (2 mg)
- High nicotine dependence: Patch (21 mg) and Lozenge (4 mg) or Gum (4 mg)
Regardless of the level of nicotine addiction and subsequent dose of nicotine replacement therapy (NRT), participants of this trials are described as "recipients of NRT products".
干预措施: Nicotine gum (Drug)
Cessation intervention
All participants will receive nicotine replacement therapy and a referral to both Maryland Quitline and Johns Hopkins Tobacco Treatment Clinic for continued cessation care.
Nicotine replacement therapy: Nicoderm patches, gum, lozenges
- Low nicotine dependence: Lozenge (2 mg) or Gum (2 mg) or Patch (7 mg)
- Moderate nicotine dependence: Patch (14 mg) and Lozenge (2 mg) or Gum (2 mg)
- High nicotine dependence: Patch (21 mg) and Lozenge (4 mg) or Gum (4 mg)
Regardless of the level of nicotine addiction and subsequent dose of nicotine replacement therapy (NRT), participants of this trials are described as "recipients of NRT products".
干预措施: Nicotine patch (Drug)
Cessation intervention
All participants will receive nicotine replacement therapy and a referral to both Maryland Quitline and Johns Hopkins Tobacco Treatment Clinic for continued cessation care.
Nicotine replacement therapy: Nicoderm patches, gum, lozenges
- Low nicotine dependence: Lozenge (2 mg) or Gum (2 mg) or Patch (7 mg)
- Moderate nicotine dependence: Patch (14 mg) and Lozenge (2 mg) or Gum (2 mg)
- High nicotine dependence: Patch (21 mg) and Lozenge (4 mg) or Gum (4 mg)
Regardless of the level of nicotine addiction and subsequent dose of nicotine replacement therapy (NRT), participants of this trials are described as "recipients of NRT products".
干预措施: Maryland Quitline (Other)
Cessation intervention
All participants will receive nicotine replacement therapy and a referral to both Maryland Quitline and Johns Hopkins Tobacco Treatment Clinic for continued cessation care.
Nicotine replacement therapy: Nicoderm patches, gum, lozenges
- Low nicotine dependence: Lozenge (2 mg) or Gum (2 mg) or Patch (7 mg)
- Moderate nicotine dependence: Patch (14 mg) and Lozenge (2 mg) or Gum (2 mg)
- High nicotine dependence: Patch (21 mg) and Lozenge (4 mg) or Gum (4 mg)
Regardless of the level of nicotine addiction and subsequent dose of nicotine replacement therapy (NRT), participants of this trials are described as "recipients of NRT products".
干预措施: John Hopkins Tobacco Treatment Clinic (Other)
结局指标
主要结局
Change in Self-reported attempts to quit smoking
时间窗: Baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months
Change in caregiver self-reported tobacco cessation attempt in the past 14-days.
次要结局
- Change in Frequency of usage of outpatient tobacco cessation services(Baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months)
- Change in Usage of nicotine replacement therapy products(Baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months)